These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17251541)

  • 1. Atypical antipsychotic drugs and Alzheimer's disease.
    Hussain HM; Hotopf M; Oyebode F
    N Engl J Med; 2007 Jan; 356(4):416; author reply 417-8. PubMed ID: 17251541
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease--clinical trials and the logic of clinical purpose.
    Karlawish J
    N Engl J Med; 2006 Oct; 355(15):1604-6. PubMed ID: 17035654
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic drugs and Alzheimer's disease.
    Jockers-Scherübl MC; Hellweg R
    N Engl J Med; 2007 Jan; 356(4):416-7; author reply 417-8. PubMed ID: 17256186
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are atypical antipsychotics safe in patients with Alzheimer's disease?
    Jones SS
    Am Fam Physician; 2006 Aug; 74(3):414. PubMed ID: 16913159
    [No Abstract]   [Full Text] [Related]  

  • 6. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 7. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
    Riva E; Nobili A; Trecate F
    Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
    Gonzalez-Moneo MJ; Simó M; Pie M; Rivero D
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1095-7. PubMed ID: 18613282
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concomitant therapies in the clinical trial in Alzheimer's disease].
    Bermejo F; Ferrari JM
    Rev Neurol; 1995; 23(119):118-24. PubMed ID: 8548604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipsychotic drugs].
    Kurita T; Koyama T
    Nihon Rinsho; 2012 Jan; 70(1):63-6. PubMed ID: 22413494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental disorders in the elderly.
    Stern LZ; Bernick C
    Compr Ther; 1987 May; 13(5):43-50. PubMed ID: 2884074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.